| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |